RPRX logo

Royalty Pharma plc

RPRX
Healthcare|Medical - Pharmaceuticals|US
$67.30
-0.27 (-0.40%)
DCF Value
$20.18
Tangible Book / Share
$19.93
Graham Number
$22.85
Cash / Share
$1.22
Next Earnings Report
Feb 10, 2027
EPS est. $1.53 · Revenue est. $960.7M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Royalty Pharma reports third quarter 2026 results
Nov 4, 2026 · GlobeNewsWire
Royalty Pharma declares fourth quarter 2026 dividend
Oct 16, 2026 · GlobeNewsWire
Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026
Oct 9, 2026 · GlobeNewsWire
Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program
Sep 15, 2026 · GlobeNewsWire
Royalty Pharma to present at upcoming investor conferences
Sep 9, 2026 · GlobeNewsWire
Royalty Pharma announces update on Novartis' Phase 3 topline results for pelacarsen
Sep 4, 2026 · GlobeNewsWire
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Aug 12, 2026 · GlobeNewsWire
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Aug 12, 2026 · GlobeNewsWire

SEC Filings (72)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Aug 17, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 14, 202613F-NTInstitutional holdings reportDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jun 16, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 28, 20268-KMaterial eventDocumentIndex
May 14, 202613F-NTInstitutional holdings reportDocumentIndex
May 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 6, 202610-QQuarterly reportDocumentIndex
May 6, 20268-KMaterial eventDocumentIndex
Apr 13, 20268-KMaterial eventDocumentIndex
Apr 10, 2026ARSAnnual report to holdersDocumentIndex
Apr 10, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 10, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 1, 202613F-NTInstitutional holdings reportDocumentIndex
Feb 20, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 11, 202610-KAnnual reportDocumentIndex
Feb 11, 20268-KMaterial eventDocumentIndex
Dec 22, 20258-KMaterial eventDocumentIndex
Dec 22, 20258-KMaterial eventDocumentIndex
Nov 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 5, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 5, 202510-QQuarterly reportDocumentIndex
Nov 5, 20258-KMaterial eventDocumentIndex
Oct 30, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Sep 16, 20258-KMaterial eventDocumentIndex
Sep 3, 2025424B2Offering prospectusDocumentIndex
Sep 3, 2025FWPDocumentIndex
Sep 2, 2025424B2Offering prospectusDocumentIndex
Sep 2, 2025POSASRDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20258-KMaterial eventDocumentIndex
Aug 13, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex